1. Home
  2. KVHI vs RNAC Comparison

KVHI vs RNAC Comparison

Compare KVHI & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

HOLD

Current Price

$9.07

Market Cap

208.4M

Sector

Technology

ML Signal

HOLD

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$6.59

Market Cap

243.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVHI
RNAC
Founded
1978
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.4M
243.0M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
KVHI
RNAC
Price
$9.07
$6.59
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$34.00
AVG Volume (30 Days)
284.2K
165.6K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
N/A
EPS
0.03
N/A
Revenue
$9,622,000.00
$2,797,000.00
Revenue This Year
$28.90
N/A
Revenue Next Year
$31.85
N/A
P/E Ratio
$294.00
N/A
Revenue Growth
3.82
N/A
52 Week Low
$5.09
$5.60
52 Week High
$13.00
$14.56

Technical Indicators

Market Signals
Indicator
KVHI
RNAC
Relative Strength Index (RSI) 39.54 44.09
Support Level $8.80 $6.07
Resistance Level $9.41 $6.60
Average True Range (ATR) 0.98 0.73
MACD -0.29 -0.08
Stochastic Oscillator 9.80 16.61

Price Performance

Historical Comparison
KVHI
RNAC

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Share on Social Networks: